Search

everythinglearnresearchcommunity

for

Search:↓

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Potassium channel openers like minoxidil boost hair growth.

Jamogenin from plants may help hair growth and is a potential alternative to finasteride.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

New compounds may help treat prostate issues without affecting androgen receptors.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Suppressing ODC activity reduces tumor growth in hair follicles.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.

The compounds tested could potentially treat hair loss and alopecia.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Isoconazole nitrate stays effective in skin and hair follicles for up to two weeks after use.

Finasteride may help prevent prostate cancer.

Combination therapy is more effective for prostate volumes over 60 ml.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

TS-13 speeds up hair regrowth after chemotherapy.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.